Do Statins Raise Blood Sugar? What the Evidence Actually Shows
Statins do raise glucose slightly. The cardiovascular benefit substantially outweighs it — and the answer is never to stop one on your own.
Let me put the conclusion first, because this topic generates a lot of anxious searching and some genuinely dangerous decisions.
Statins are associated with a small increase in blood glucose and in new diagnoses of type 2 diabetes. The cardiovascular benefit substantially outweighs that risk for the people they're prescribed to. Do not stop a statin because your glucose rose.
Now the detail.
What's actually established
The FDA added information to statin labelling noting that increases in HbA1c and fasting glucose have been reported, while stating that the cardiovascular benefits outweigh these small increased risks.
Meta-analyses of randomized trials put the increase in new-onset diabetes at roughly 9 to 12% in relative terms. In absolute terms that's small — one analysis estimated about one additional case per 255 people treated over four years.
The effect is dose-related — greater with high-intensity therapy — and concentrated in people who already have prediabetes or metabolic syndrome. If your glucose was already drifting, you're in the group where this is most likely to be visible.
The scale of the trade-off
This is the number that puts it in proportion. In primary prevention, one analysis estimated the increased risk of diabetes to be more than fiftyfold smaller than the absolute cardiovascular benefit — roughly 0.2 additional diabetes cases per 1,000 people treated against 11 major cardiovascular events prevented.
The American Heart Association's scientific statement on statin safety concluded that the cardiovascular benefits far outweigh the new-onset diabetes risk.
What to do if your glucose rose after starting one
Not stop it. Guidelines specifically recommend continuing statin therapy even if glucose rises.
Tell your doctor. This is a known effect and worth having on record. Monitoring may change.
Ask whether the intensity is right for your risk. Not whether to stop — whether the dose matches your cardiovascular risk. That's a legitimate question with a real answer.
Address the glucose side directly. Lifestyle change works on this the same way it works otherwise, and it's the appropriate response rather than discontinuation.
The thing worth understanding
Statins are prescribed to people who already have elevated cardiovascular risk — and having prediabetes or metabolic syndrome is itself part of why some of them were prescribed. The populations overlap heavily, which makes attribution harder than headlines suggest.
That doesn't mean the effect isn't real. It means the person most likely to notice it is also the person most likely to have needed the statin.
Try this week: if this concerns you, book a conversation about it rather than making a decision about it. That's the whole recommendation.
Education, not medical advice. Never stop or change a prescribed statin without speaking to your prescriber.
Sources
- Statins may increase diabetes, but benefit still outweighs risk. *Cleveland Clinic Journal of Medicine* 2023;90(1):53 View source
- Goldfine AB. Statins: is it really time to reassess benefits and risks? *New England Journal of Medicine* 2012 View source
- Statins and risk of new-onset diabetes mellitus: is there a rationale for individualized statin therapy? View source